{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:00:28Z","timestamp":1790625628285,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PCT-010000-2010-3"],"award-info":[{"award-number":["PCT-010000-2010-3"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PPT-300000-2009-2011"],"award-info":[{"award-number":["PPT-300000-2009-2011"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuropharm.2015.09.029","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T05:35:16Z","timestamp":1445232916000},"page":"538-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Protective effects of isolecanoric acid on neurodegenerative in\u00a0vitro models"],"prefix":"10.1016","volume":"101","author":[{"given":"Nuria","family":"de Pedro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cantizani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Ortiz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gonz\u00e1lez-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Cautain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Bills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1607-5106","authenticated-orcid":false,"given":"Fernando","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Genilloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.neuropharm.2015.09.029_bib2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neurobiolaging.2010.01.004","article-title":"Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease","volume":"32","author":"Armentero","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S095375629800687X","article-title":"Reclassification of a pneumocandin-producing anamorph, Glarealozoyensis gen. et sp. nov., previously identified as Zalerionarboricola","volume":"103","author":"Bills","year":"1999","journal-title":"Mycol. Res."},{"issue":"11\u201312","key":"10.1016\/j.neuropharm.2015.09.029_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","article-title":"Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target","volume":"1762","author":"Barber","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.neuropharm.2015.09.029_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2015.09.029_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.neuroscience.2009.11.034","article-title":"Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord","volume":"165","author":"Caldero","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A\u00a0highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.09.029_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0891-5849(93)90027-R","article-title":"Oxygen-radical absobance capacity assay for antioxidants","volume":"14","author":"Cao","year":"1993","journal-title":"Free Radic. Bil. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bcp.2008.04.010","article-title":"GSK3beta and endoplasmic reticulum stress mediate rotenone-induced death of SK-N-MC neuroblastoma cells","volume":"76","author":"Chen","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"31","key":"10.1016\/j.neuropharm.2015.09.029_bib10","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1523\/JNEUROSCI.1972-07.2007","article-title":"An endogenous serine\/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease","volume":"27","author":"Chung","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.09.029_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/36.9.2457047","article-title":"Measurement of cell-cycle phase-specific cell death using Hoechst 33342 and propidium iodide: preservation by ethanol fixation","volume":"36","author":"Ciancio","year":"1988","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2015.09.029_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson's disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.etap.2013.04.007","article-title":"Beta-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS","volume":"36","author":"de Munck","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.029_bib14","doi-asserted-by":"crossref","first-page":"e005528","DOI":"10.1136\/bmjopen-2014-005528","article-title":"Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme","volume":"4","author":"Delzor","year":"2014","journal-title":"BMJ Open"},{"issue":"Pt 7","key":"10.1016\/j.neuropharm.2015.09.029_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J.\u00a0Cell Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.09.029_bib16","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Hum. Genet."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.029_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","article-title":"Glycogen synthase kinase 3: an emerging therapeutic target","volume":"8","author":"Eldar-Finkelman","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.029_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2009.09.003","article-title":"Wnt signaling in development and disease","volume":"38","author":"Freese","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.21687","article-title":"Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases","volume":"65","author":"Garcia-Gorostiaga","year":"2009","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","article-title":"Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord","volume":"85","author":"Hu","year":"2003","journal-title":"J.\u00a0Neurochem."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.029_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0022-1759(95)00172-7","article-title":"YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability","volume":"185","author":"Idziorek","year":"1995","journal-title":"J.\u00a0Immunol. Methods"},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib26","first-page":"123","article-title":"Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators","volume":"120","author":"Jiang","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.09.029_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/00016480600951400","article-title":"Cell proliferation, apoptosis, and apoptosis inhibition in malignant transformation of sinonasal inverted papilloma","volume":"127","author":"Katori","year":"2007","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.neuropharm.2015.09.029_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-5-47","article-title":"Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model","volume":"5","author":"Khandelwal","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuron.2006.10.031","article-title":"Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth","volume":"52","author":"Kim","year":"2006","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2015.09.029_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03033861","article-title":"Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency","volume":"14","author":"King","year":"2008","journal-title":"Neurotox. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/scdb.2001.0282","article-title":"Reactive oxygen species and mitochondrial diseases","volume":"12","author":"Kirkinezos","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cmdc.200500039","article-title":"Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease","volume":"1","author":"Kozikowski","year":"2006","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.20691","article-title":"GSK3B polymorphisms alter transcription and splicing in Parkinson's disease","volume":"58","author":"Kwok","year":"2005","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.neuropharm.2015.09.029_bib35","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: relevance to Parkinson's disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.neuropharm.2015.09.029_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/np1000945","article-title":"An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds","volume":"73","author":"Liu","year":"2010","journal-title":"J.\u00a0Nat. Prod."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2008.10.104","article-title":"Glycogen synthase kinase-3beta is associated with Parkinson's disease","volume":"449","author":"Nagao","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"20","key":"10.1016\/j.neuropharm.2015.09.029_bib38","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.2174\/092986711796391697","article-title":"The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy","volume":"18","author":"Palomo","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/taap.2001.9159","article-title":"Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid","volume":"173","author":"Panaretakis","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21501203.2010.544334","article-title":"Phylogeny and intercontinental distribution of the pneumocandin-producing anamorphic fungus Glarea lozoyensis","volume":"2","author":"Pel\u00e1ez","year":"2011","journal-title":"Mycol. Int. J. Fungal Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.029_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.20207","article-title":"Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases","volume":"31","author":"Perez","year":"2011","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-8993(96)00527-6","article-title":"Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells","volume":"733","author":"Satoh","year":"1996","journal-title":"Brain Res."},{"issue":"34","key":"10.1016\/j.neuropharm.2015.09.029_bib43","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2015.09.029_bib44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.neuropharm.2015.09.029_bib45","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice","volume":"20","author":"Sugai","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.029_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1056-8719(98)00016-1","article-title":"In\u00a0vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium lauryl sulfate cytotoxicity","volume":"39","author":"Verhulst","year":"1998","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.029_bib47","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","article-title":"Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.neuropharm.2015.09.029_bib48","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1523\/JNEUROSCI.16-18-05688.1996","article-title":"Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure","volume":"16","author":"White","year":"1996","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","article-title":"Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia","volume":"225","author":"Wills","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.029_bib50","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11064-013-0980-9","article-title":"Physiological role of b-Catenin\/TCF signaling in neurons of the adult brain","volume":"38","author":"Wisniewska","year":"2013","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.029_bib51","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in\u00a0vitro cell model of dopaminergic neurons in Parkinson's disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin. Med. J. Engl."},{"key":"10.1016\/j.neuropharm.2015.09.029_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2007.12.031","article-title":"Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)","volume":"1196","author":"Yang","year":"2008","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.029_bib53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0012-1606(03)00123-4","article-title":"BetaCatenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system","volume":"258","author":"Zechner","year":"2003","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.029_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","article-title":"The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease","volume":"532","author":"Zuo","year":"2013","journal-title":"Gene"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:56:49Z","timestamp":1762214209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":54,"alternative-id":["S0028390815301210"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of isolecanoric acid on neurodegenerative in\u00a0vitro models","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}